AMBEV S.A. current report, Q4 FY2019

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the reporting period of October 1 to October 31, 2019, with the report signed on November 7, 2019. The document serves as a consolidated report of securities transactions by management and related persons in compliance with Article 11 of CVM Instruction # 358/2002. It does not contain operational or financial performance data for the company.

Key Financial Metrics

The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The document exclusively details insider trading activity.

Category Transaction Type Quantity Total Volume (R$)
Board of Directors Net Activity None None
Management Purchases (Common Shares) 201,000 R$ 2,455,758.28
Management Sales (Common Shares) 119,852 R$ 2,254,461.06
Management Sales (ADR Common) 81,215 R$ 1,575,462.57
Management Net Position Change (Shares) +81,148 N/A

Material Changes

There were no material changes reported for the Board of Directors or the Fiscal Council during the period. For Management, there was a net increase in common share holdings of 81,148 shares and a net decrease in ADR holdings of 81,215 units. The filing does not provide prior period data for comparison.

Guidance, Outlook, and Risks

The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider transactions.

Investor Verification Checklist

  • Verify the net increase in common share ownership by Management (81,148 shares) versus the net decrease in ADRs.
  • Confirm the specific dates of transactions, which occurred primarily on October 3 and October 25, 2019.
  • Note that the Board of Directors reported no transactions during this month.
  • Review the price range for common shares traded, which varied between approximately R$ 2.26 (option exercise) and R$ 18.87 (market sales).